Skip to main navigation Skip to search Skip to main content

Cross linking of anti-B16 melanoma monoclonal antibodies to lymphokine activated killer (LAK) cells: possible role in the therapy of B16 melanoma

  • Avi Eisenthal*
  • , Steven A. Rosenberg
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Cross linking of anti-B16 melanoma monoclonal antibodies to lymphokine activated killer (LAK) cells: possible role in the therapy of B16 melanoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology